CIK 0002042347
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Seaport Therapeutics, Inc.
Sign in to watch- Ticker
- SPTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 992235719
- Phone
- +1 617-807-4062
- Business address
- 6 TIDE STREET, SUITE 400, BOSTON, MA, 02110
- Open-market buys, last 90 days
- $99,325
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$99,325. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-05-04 | ARCH Venture Partners XII, LLC 10% owner | Conversion | +2,513,686 | 2,513,686 | ||
| 2026-05-04 | ARCH Venture Partners XII, LLC 10% owner | Conversion | +2,681,265 | 5,194,951 | ||
| 2026-05-04 | ARCH Venture Partners XII, LLC 10% owner | Purchase | +1,100,000 | $18.00 | $19.8M | 6,294,951 |
| 2026-05-04 | ARCH Venture Partners XII, LLC 10% owner | Conversion · Series A-2 Preferred Stock | −2,513,686 | 0 | ||
| 2026-05-04 | ARCH Venture Partners XII, LLC 10% owner | Conversion · Series B Preferred Stock | −2,681,265 | 0 |
Page 1 of 1 · 5 trades